Status:
COMPLETED
REVEAL III: Risk Evaluation and Education for Alzheimer's Disease
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
National Human Genome Research Institute (NHGRI)
Conditions:
Alzheimer Disease
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The purpose of this study is to provide healthy adults with genetic testing and information about their chances of developing Alzheimer's disease.
Detailed Description
Alzheimer's disease is a common condition affecting memory and thinking. Genes can sometimes be used to provide risk estimates for the eventual development of certain common diseases. Apolipoprotein E...
Eligibility Criteria
Inclusion
- Aged 18 years to 85 years old
Exclusion
- Unable to visit a study site
- Current untreated depression or anxiety
- Family history of AD diagnosed under age 60
- More than one first-degree relative diagnosed with AD (e.g. Mother and brother)
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
290 Patients enrolled
Trial Details
Trial ID
NCT00462917
Start Date
March 1 2007
End Date
October 1 2009
Last Update
October 23 2018
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Howard University
Washington D.C., District of Columbia, United States, 20059
2
Boston University School of Medicine
Boston, Massachusetts, United States, 02118
3
University of Michigan
Ann Arbor, Michigan, United States, 48109
4
Case Western Reserve University
Cleveland, Ohio, United States, 44120